Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2016-11-25 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
关于2016年1-9月业绩下滑事项不影响非公开发行股票的提醒性公告
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from a company about its financial performance for the first nine months of 2016, specifically discussing a decline in earnings and the reasons behind it. It includes detailed financial figures such as revenue, net profit, gross profit, and expenses, as well as explanations of operational challenges and strategic responses. The document also discusses risks, management measures, and the impact of the performance on a non-public stock issuance. The length is over 6,000 characters and contains substantive financial data and analysis, not just a brief announcement or a certification. It is not a full annual report but rather a comprehensive interim performance report covering a specific period (January to September 2016). Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2016
2016-11-25 Chinese
关于公司第二大股东解除部分股权质押的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the release of a partial pledge on shares by the company's second largest shareholder. It contains no financial statements or detailed financial data, but rather informs about a change in share pledge status. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about share pledge status and does not fit into more specific categories like Share Issue/Capital Change or Director's Dealing. The document length is short (627 characters), and it is not a report or a detailed financial disclosure.
2016-11-24 Chinese
关于非公开发行股票申请获得中国证监会发行审核委员会审核通过的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding the approval of a non-public stock issuance application by the China Securities Regulatory Commission's issuance review committee. It mentions that the company has not yet received the formal approval document and will announce it later. The document is brief (443 characters) and serves as an update on a financing activity rather than a full report or detailed financial data. Therefore, it fits the category of Capital/Financing Update (CAP).
2016-11-18 Chinese
关于参加2016年湖南辖区上市公司投资者网上接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is an announcement about the company's participation in an online investor reception day event. It mentions interaction with investors regarding the company's 2016 third quarter report and other topics but does not contain the report itself or detailed financial data. The document is short (622 characters) and serves as a notice of an event rather than a financial report or transcript. Therefore, it fits best as a Regulatory Filing (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2016-10-31 Chinese
2016年第三季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2016 Third Quarter Report" of 启迪古汉集团股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data such as total assets, net profit, earnings per share, cash flow, and changes in shareholders, which are typical contents of an interim or quarterly report. The document length is 8071 characters, which is substantial and contains actual financial statements and analysis, not just an announcement or summary. There is no indication that this is an annual report, audit report, or earnings release. The presence of detailed financial tables and explanations confirms it is a comprehensive quarterly report rather than a brief earnings release or announcement. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2016
2016-10-26 Chinese
独立董事关于选举公司副董事长的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding the election of a company's vice chairman, referencing regulatory guidelines and company governance rules. It is a governance-related announcement about board member election approval, not a full report or financial statement. The content fits best under Board/Management Information (MANG) as it concerns board composition and management changes.
2016-10-26 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.